Parallel Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Parallel Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.9K	Sell	153 -29	-16%	-$6.25K	﹤0.01%	2311
2026 Q1	$36.5K	Buy	182 +169	+1,300%	+$35K	﹤0.01%	2180
2025 Q4	$2.69K	Hold	13	–	–	﹤0.01%	3055
2025 Q3	$2.33K	Hold	13	–	–	﹤0.01%	3009
2025 Q2	$2.1K	Hold	13	–	–	﹤0.01%	3034
2025 Q1	$2.21K	Hold	13	–	–	﹤0.01%	2950
2024 Q4	$2.16K	Hold	13	–	–	﹤0.01%	2944
2024 Q3	$2.23K	Hold	13	–	–	﹤0.01%	2861
2024 Q2	$2K	Sell	13 -8	-38%	-$1.2K	﹤0.01%	2811
2024 Q1	$3.23K	Sell	21 -15	-42%	-$2.29K	﹤0.01%	2662
2023 Q4	$5.69K	Hold	36	–	–	﹤0.01%	2484
2023 Q3	$5.27K	Buy	+36	New	+$5.49K	﹤0.01%	2486
2022 Q3	–	Sell	-48	Closed	-$7K	–	3249
2022 Q2	$7K	Buy	+48	New	+$6.62K	﹤0.01%	2127
2019 Q3	–	Sell	-20	Closed	-$3K	–	2416
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	1976
2019 Q1	$3K	Buy	+20	New	+$2.88K	﹤0.01%	1964

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Parallel Advisors's FBT Position: Q2 2026 in Review

Parallel Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 16% in Q2 2026, selling an estimated $6.25K and leaving 153 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

Parallel Advisors first reported a position in FBT in Q1 2019 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Parallel Advisors held 153 shares of First Trust NYSE Arca Biotechnology Index Fund worth $37.9K as of Q2 2026.
Parallel Advisors sold 29 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $6.25K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2311 holding.
Parallel Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 15 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.